Regulatory perspectives on CQAs, CPPs, and Risk …
Global Regulatory Affairs Regulatory perspectives on CQAs, CPPs, and Risk Analyses for Combination Products. 3rd FDA/PQRI Conference on Advancing Product Quality
Download Regulatory perspectives on CQAs, CPPs, and Risk …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Hazard & Operability Analysis (HAZOP) 1 Overview
pqri.orgManufacturing Technology Committee – Risk Management Working Group Risk Management Training Guides Hazard & Operability Analysis (HAZOP) Page 1 of 9 1 Overview Hazard and Operability Analysis (HAZOP) is a …
Failure Modes and Effects Analysis Guide
pqri.orgManufacturing Technology Committee – Risk Management Working Group Risk Management Training Guides Failure Modes and Effects Analysis Guide 1 Overview Failure Modes and Effects Analysis (FMEA) is …
CMC Regulatory Considerations for …
pqri.orgCMC Regulatory Considerations for Oligonucleotide Drug Products: FDA Perspective Mohan Sapru, M.S., Ph.D. CMC Lead for Cardiovascular and Renal Products
ICH Q12 : A Unique Opportunity to Realize 21st …
pqri.orgICH Q12 : A Unique Opportunity to Realize 21st Century Quality Vision . Moheb M. Nasr . 3rd FDA/PQRI Conference . March 22, 2017
INTRODUCTION TO POLYMER ADDITIVES AND …
pqri.orgINTRODUCTION TO POLYMER ADDITIVES AND STABILIZATION Bobbijo van Beusichem, Ph.D., Senior Staff Scientist, Expert Services, Michael A. Ruberto, Ph.D., Head of Regulatory Services, NAFTA, Expert Services
Thresholds and Best Practices for Extractable and …
pqri.orgOverview of Thresholds and Best Practices for Extractable and Leachables(L&E) 3rd PQRI/FDA Conference on Advancing Product Quality Washington DC, 22 …
Harmonization of Requirements Between ICH Q3D …
pqri.orgHarmonization of Requirements Between ICH Q3D and Pharmacopeias Kahkashan Zaidi, USP PQRI/USP Workshop on Elemental Impurities March 31 – April 1, 2015 USP Rockville, Maryland
European reflections on reviewing NDAs and …
pqri.orgEuropean reflections on reviewing NDAs and ANDAs for ICH Q3D elemental impurity compliance Diana van Riet-Nales, Medicines Evaluation Board/NL
Recommendations for the Assessment of Blend …
pqri.orgRecommendations for the Assessment of Blend and Content Uniformity: Modern Approaches to Sampling and Testing James K. Drennen, III drennen@duq.edu
Nanoparticle Size Analysis: A Survey and Review - …
pqri.orgIntroduction In 2014 the Nanomedicines Alliance conducted a blinded survey of its member companies on the topic of particle size analysis. The survey was followed by an
Related documents
9. Cardiovascular Disease and Risk Management: …
care.diabetesjournals.orgwiththeacknowledgmentthattheben-efits and risks of intensive blood pres-suretargetsareuncertainandmayvary across patients (5).Similar tothefactors
Interpreting a Decision Tree Analysis of ... - …
litigationrisk.com1 INTERPRETING A DECISION TREE ANALYSIS OF A LAWSUIT by Marc B. Victor More and more attorneys are evaluating lawsuits by performing decision tree analyses …
Hazard & Operability Analysis (HAZOP) 1 Overview
pqri.orgManufacturing Technology Committee – Risk Management Working Group Risk Management Training Guides Hazard & Operability Analysis (HAZOP) Page 1 of 9 1 Overview Hazard and Operability Analysis (HAZOP) is a …
Risk Analysis of Sterile Production Plants: A New …
www.gappquality.comTECH REPORT Risk Analysis of Sterile Production Plants: A New and Simple, Workable Approach GUENTHER GAPP1* and PETER HOLZKNECHT2 1Quality Assurance Microbiology, Sandoz GmbH/Novartis, Kundl, Austria and 2Biotechnological Production, Sandoz GmbH/Novartis, Kundl, Austria ©PDA, Inc. 2011
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
NARDIL - Pfizer
www.pfizer.com1 NARDIL® (Phenelzine Sulfate Tablets, USP) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior